Mark A. Preston
Papers
10
Total Citations
379
H-Index
6
About
Mark A. Preston is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for prostate and bladder cancer, with a particular emphasis on robotic-assisted techniques and perioperative care. His most cited work, a 2016 analysis of over 400,000 patients from an all-payer database, demonstrated that robot-assisted radical prostatectomy significantly reduces complications and transfusion rates compared to open surgery, accumulating 227 citations and shaping modern surgical practice. Preston has also made critical contributions to understanding the costs and safety of radical cystectomy for bladder cancer, including a 2017 study revealing wide cost variations across US hospitals (83 citations) and a 2021 paper showing robotic-assisted cystectomy lowers perioperative mortality in octogenarians. His prospective, randomized trial on intravenous acetaminophen for robotic prostatectomy (2018) provided evidence for enhanced recovery protocols, while his population-based analyses of rhabdomyolysis after renal surgery (2015) established contemporary incidence rates and risk factors. Preston’s work consistently bridges large-scale database research with clinical trials, advancing both the safety and value of urologic cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2Variations in the Costs of Radical Cystectomy for Bladder Cancer in the USA83 citations · 2017
- 3
- 4
- 5New Trends in the Surgical Management of Invasive Bladder Cancer12 citations · 2015
- 6
- 7
- 8
- 9Impact of COVID-19 pandemic on ambulatory urologic oncology surgeries.2 citations · 2023
- 10